Intraocular sustained release drug delivery systems and methods for treating ocular conditions

Details for Australian Patent Application No. 2010229891 (hide)

Owner Allergan, Inc.

Inventors Robinson, Michael R.; Burke, James A.; Liu, Hui; Orilla, Werhner C.; Spada, Lon T.; Whitcup, Scott; Ghebremeskel, Alazar N.; Hughes, Patrick M.; Xu, Kun; Do, Marianne M.

Agent Davies Collison Cave

Pub. Number AU-A-2010229891

PCT Pub. Number WO2010/111449

Priority 12/411,250 25.03.09 US

Filing date 25 March 2010

Wipo publication date 30 September 2010

International Classifications

A61K 31/5575 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

20 October 2011 PCT application entered the National Phase

  PCT publication WO2010/111449 Priority application(s): WO2010/111449

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229900-Bioerodible matrix for tissue involvement

2010229884-Emergency and traffic alert system